Clinical Features of Patients with Measles during 2000-2001.
- Author:
Sung Ryon AHN
1
;
Su En PARK
Author Information
1. Department of Pediatrics, College of Medicine, Busan National University, Busan, Korea. pse0731@hanmail.net
- Publication Type:Original Article
- Keywords:
Measles;
MMR
- MeSH:
Age Distribution;
Busan;
Child;
Disease Outbreaks;
Humans;
Immunity, Herd;
Immunization, Secondary;
Immunoenzyme Techniques;
Immunoglobulin G;
Immunoglobulin M;
Incidence;
Infant;
Meals;
Measles*;
Prevalence;
Vaccination;
Vaccines
- From:Journal of the Korean Pediatric Society
2002;45(8):980-986
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Although the number of patients with measles have dramatically decreased since the introduction of measles vaccines in 1965, measles outbreaks have occurred periodically every 4-6 years during the 1990s(1989-1990 and 1993-1994). During 2000-2001, measles prevailed all over the country again. A characteristic of current epidemics is that the majority of affected population was infants and school-aged children. This study was designed to analyze the epidemic and clinical features of measles prevalence during 2000-2001 and to find ways to overcome vaccination failure. METHODS: We reviewed the records of 59 patients with mealses admitted in the Pediatric Department of Pusan National University Hospital from January 2000 to October 2001 for patient's age, month of admission, history of vaccination, clinical features and complications. Antibody titers of measles-specific IgM and IgG were measured by enzyme immunoassay. RESULTS: The epidemic show two peaks in the age distribution. Forty three patients(72.9%) were under 2-years of age and 14 patients(23.7%) were over 5-years of age. Outbreaks had high incidence in July to August, 2000 and March to April, 2001, then faded away after July, 2001. Vaccinated group comprised 30.5% and unvaccinated group comprised 69.5% and their mean age was 9.25+/-4.27 years old and 0.95+/-0.30 years old respectively. Positive rate of IgM was 86.7% in vaccinated group and 90.3% in unvaccinated group. This means there was primary vaccine failure; 13 cases of 15 vaccinated patients were positive in IgM antibody. During the prevalence, two patients died with mealses complication. One of them was immunocompromised. CONCLUSION: To prevent another prevalence of measles in the future, we must enhance revaccination at ages 4-6 and check vaccination status when children enter elementary school. These will produce over 95% of herd immunity, with catch-up MMR vaccination which has been completed already.